Delivery Order SPE2DB20D9331-SPE2DB25FL2C6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, issued on June 2, 2025, with an ultimate completion date of June 24, 2025, was awarded without a set-aside designation. The award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, carries no set-aside designation. The award represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The award, issued on August 14, 2025, with an ultimate completion date of September 5, 2025, carries a firm fixed-price arrangement with no set-aside designation. This delivery order represents a single transaction under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a $65,000 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This delivery order, issued on July 31, 2025, represents an individual task order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $500 million and extending through November 2026. The delivery order carries an...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. The contract, awarded on August 19, 2025, with an ultimate completion date of September 10, 2025, operates under a firm fixed-price arrangement with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, carries no set-aside designation. The award was issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with an ultimate completion date of September 30, 2025. The contract utilizes a firm fixed-price structure with no set-aside designation, allowing the vendor to compete on an open basis despite its small...
- The Defense Logistics Agency awarded a delivery order valued at $8,220.68 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this contract at its Park Ridge facility. The delivery order is structured as a firm fixed-price contract with an ultimate completion date of May 13, 2025, and no set-aside designation was applied to this...
- The Defense Logistics Agency awarded a delivery order valued at $16,154.36 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with an ultimate completion date of October 17, 2025. This delivery order was awarded on a firm fixed-price basis with no set-aside designation, allowing the vendor to compete on an open basis despite its...
- The Defense Logistics Agency awarded a delivery order valued at $48,749.85 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with an ultimate completion date of September 16, 2025. This delivery order was awarded on a firm fixed-price basis with no set-aside designation, allowing the company to compete directly in the federal...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB25FL2C6Delivery Order
The Defense Logistics Agency awarded a $387,704.64 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The award, issued on September 27, 2025, with an ultimate completion date of October 20, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $500 million through November 2026, which enables the agency to procure a comprehensive portfolio of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities nationwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain through its SPE2DB program contract with the Defense Logistics Agency. The company's extensive contract portfolio demonstrates consistent success in delivering specialized pharmaceutical products including prescription medications, biologics, and medical consumables directly to military health facilities. This particular delivery order for Stelara, a biologic medication used in treating inflammatory conditions, exemplifies the company's role in ensuring reliable access to branded pharmaceutical products for the Defense Department's healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $387.7k | 9/27/25 |